UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease?

Chia, Mark A; Keane, Pearse A; (2022) Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease? The Lancet , 399 (10326) pp. 697-699. 10.1016/S0140-6736(22)00105-2. Green open access

[thumbnail of Keane_Comment_Manuscript - Revised _26Nov21_3.0 - MC comments CLEAN_updated disclosure.pdf]
Preview
Text
Keane_Comment_Manuscript - Revised _26Nov21_3.0 - MC comments CLEAN_updated disclosure.pdf

Download (120kB) | Preview
Type: Article
Title: Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease?
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/S0140-6736(22)00105-2
Publisher version: https://doi.org/10.1016/S0140-6736(22)00105-2
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
URI: https://discovery.ucl.ac.uk/id/eprint/10143834
Downloads since deposit
64Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item